TMEM16A/ANO1 calcium-activated chloride channel as a novel target for the treatment of human respiratory syncytial virus infection

TMEM16A/ANO1钙激活氯通道作为治疗人类呼吸道合胞病毒感染的新靶点

阅读:8
作者:Hayley Pearson, Eleanor J A A Todd, Mareike Ahrends, Samantha E Hover, Adrian Whitehouse, Martin Stacey, Jonathan D Lippiat, Ludwig Wilkens, Hans-Gerd Fieguth, Olga Danov, Christina Hesse, John N Barr, Jamel Mankouri

Discussion

These findings reveal TMEM16A as an exciting target for future host-directed antiviral therapeutics.

Methods

It is now established that viruses require cellular ion channel functionality to infect cells. Here, we infected human lung epithelial cell lines and ex vivo human lung slices with HRSV in the presence of a defined panel of chloride (Cl-) channel modulators to investigate their role during the HRSV life-cycle.

Results

We demonstrate the requirement for TMEM16A, a calcium-activated Cl- channel, for HRSV infection. Time-of-addition assays revealed that the TMEM16A blockers inhibit HRSV at a postentry stage of the virus life-cycle, showing activity as a postexposure prophylaxis. Another important negative-sense RNA respiratory pathogen influenza virus was also inhibited by the TMEM16A-specific inhibitor T16Ainh-A01.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。